Development of a risk prediction model for carbapenem-resistant enterobacteriaceae infection after liver transplantation: a multinational cohort study (2021)
- Authors:
- Autor USP: ABDALA, EDSON - FM
- Unidade: FM
- DOI: 10.1093/cid/ciab109
- Subjects: TRANSPLANTE DE FÍGADO; INFECÇÕES POR ENTEROBACTERIACEAE; ENTEROBACTERIACEAE; ESTUDOS DE COORTES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinical infectious diseases
- ISSN: 1058-4838
- Volume/Número/Paginação/Ano: v. 73, n. 4, p. E955-E966, 2021
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
GIANNELLA, Maddalena et al. Development of a risk prediction model for carbapenem-resistant enterobacteriaceae infection after liver transplantation: a multinational cohort study. Clinical infectious diseases, v. 73, n. 4, p. E955-E966, 2021Tradução . . Disponível em: https://doi.org/10.1093/cid/ciab109. Acesso em: 06 maio 2024. -
APA
Giannella, M., Freire, M., Rinaldi, M., Abdala, E., Rubin, A., Mularoni, A., et al. (2021). Development of a risk prediction model for carbapenem-resistant enterobacteriaceae infection after liver transplantation: a multinational cohort study. Clinical infectious diseases, 73( 4), E955-E966. doi:10.1093/cid/ciab109 -
NLM
Giannella M, Freire M, Rinaldi M, Abdala E, Rubin A, Mularoni A, Gruttadauria S, Grossi P, Shbaklo N, Tandoi F. Development of a risk prediction model for carbapenem-resistant enterobacteriaceae infection after liver transplantation: a multinational cohort study [Internet]. Clinical infectious diseases. 2021 ; 73( 4): E955-E966.[citado 2024 maio 06 ] Available from: https://doi.org/10.1093/cid/ciab109 -
Vancouver
Giannella M, Freire M, Rinaldi M, Abdala E, Rubin A, Mularoni A, Gruttadauria S, Grossi P, Shbaklo N, Tandoi F. Development of a risk prediction model for carbapenem-resistant enterobacteriaceae infection after liver transplantation: a multinational cohort study [Internet]. Clinical infectious diseases. 2021 ; 73( 4): E955-E966.[citado 2024 maio 06 ] Available from: https://doi.org/10.1093/cid/ciab109 - Management of hepatocellular carcinoma during the COVID-19 pandemic - Sao Paulo clinicas liver cancer group multidisciplinary consensus statement
- Efficacy of -Lactam/-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum--LactamaseProducing Enterobacteriaceae in Hematological Patients with Neutropenia C
- Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)
- Clinical profile and mortality predictors for tuberculosis disease among patients with solid tumours
- Contribuição científica para o manejo das infecções em transplantes de órgãos sólidos
- Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
- Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study
- Thermal and chronological stability of monocyte distribution width (MDW), the new biomarker for sepsis. [Carta]
- Endemic Fungal Infection Recommendations for Solid-Organ Transplant Recipients and Donors
- Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?
Informações sobre o DOI: 10.1093/cid/ciab109 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
